Gary A Shangold

Title: The Innovative Contributions of Gary A. Shangold

Introduction

Gary A. Shangold is a notable inventor based in Califon, New Jersey. He has made significant contributions to the field of hormone replacement therapy, holding a total of five patents. His work has had a profound impact on the medical community, particularly in the area of women's health.

Latest Patents

One of Gary A. Shangold's latest patents is for a low dose estrogen interrupted hormone replacement therapy. This innovative therapy comprises a plurality of daily doses of a pharmaceutical preparation, which are administered continuously and consecutively in alternating phases. The therapy includes a relatively dominant estrogenic activity phase, consisting of three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol. Additionally, it features a relatively dominant progestagenic activity phase, which combines a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 µg per day of norgestimate.

Career Highlights

Throughout his career, Gary A. Shangold has worked with various companies, including Duramed Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.

Collaborations

Gary has collaborated with several professionals in his field, including Robert Frederic Casper and Militza K Ausmanas. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

In summary, Gary A. Shangold is a distinguished inventor whose work in hormone replacement therapy has led to significant advancements in women's health. His innovative patents and collaborations highlight his commitment to improving medical treatments.